Clinical Trials in Arizona

Showing 6581-6600 of 12,706 trials

Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma

NCT02128282

This study considers the safety and tolerability of increasing doses of CX-4945 in combination with gemcitabine plus cisplatin to determine the maximum tolerated dose (MTD) and the recommended Phase II dose (RP2D), followed by a randomized study that compares antitumor activity in cholangiocarcinoma patients receiving the standard of care gemcitabine plus cisplatin versus CX-4945 at the combination RP2D with gemcitabine plus cisplatin.

Cholangiocarcinoma

Senhwa Biosciences, Inc.127 participantsStarted Jun 2014

Scottsdale, Arizona, United States • Aurora, Colorado, United States • Jacksonville, Florida, United States +13 more locations

COMPLETEDPhase 335 miles

Tolvaptan Extension Study in Participants With ADPKD

NCT01214421

To demonstrate whether tolvaptan modifies ADPKD progression as measured by changes from Baseline (from Study 156-04-251) in total kidney volume (TKV) and renal function.

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Otsuka Pharmaceutical Development & Commercialization, Inc.1,083 participantsStarted May 2010

Mobile, Alabama, United States • Peoria, Arizona, United States • Tempe, Arizona, United States +94 more locations

Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma

Tolvaptan Extension Study in Participants With ADPKD

Find Trials by Condition in Arizona

Convalescent Plasma in Outpatients With COVID-19

Triathlon Total Stabilizer (TS) Outcomes Study

Prospective Aneurysm Trial: High Angle Aorfix™ Bifurcated Stent Graft

Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

Non-interventional Post-authorisation Study to Document the Immunogenicity, Safety, and Efficacy of NUWIQ

An Integrated Program for the Treatment of First Episode of Psychosis

Dalantercept in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Rapid Test and Treat Dolutegravir Plus Lamivudine Study in Newly Diagnosed Human Immunodeficiency Virus (HIV)-1 Infected Adults

A Trial of Two Doses of 2',3'-Dideoxycytidine (ddC) in the Treatment of Children With Symptomatic HIV Infection Who Are Intolerant of AZT and/or Who Show Progressive Disease While on AZT

A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive Individuals

An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A

Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer

Safety and Efficacy of BRM421 for Dry Eye Syndrome Treatment

A Study of INFUSE Bone Graft (BMP-2) in the Treatment of Tibial Pseudarthrosis in Neurofibromatosis Type 1 (NF1)

Global Epidemiologic Study of Preexisting Immunity to AAV in Adults With Severe Hemophilia

B Cell Induction in Pediatric Lung Transplantation

DOT Diary Optimization Pilot: A Pilot Study to Optimize the DOT Diary App to Measure PrEP Adherence

Safety and Efficacy Study of Neratinib and Cetuximab to Treat Patients With Quadruple Wild-Type Metastatic Colorectal Cancer